On August 1, 2020, the thirty-fourth participant completed experimental treatment in our ongoing study of the effect of MDMA on startle testing in healthy volunteers. Led by Principal Investigator Barbara Rothbaum, Ph.D., this study is conducted at Emory University in Atlanta, Georgia. The MAPS Public Benefit Corporation (MAPS PBC) locked the database for this study on November 4, 2020. This officially brings the data collection phase of the study to an end. With this final set of data, the research team will analyze the data and write a paper for submission to a peer-reviewed scientific journal. • Learn More
